Latest News and Press Releases
Want to stay updated on the latest news?
-
Er-Kim and Puma Biotechnology sign agreement to commercialize NERLYNX® (neratinib) in select countries in Eastern Europe and Central Asia
-
Aclarion Announces Commercial Agreement with Spine Institute of Louisiana
-
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory
-
SAN DIEGO, April 22, 2025 (GLOBE NEWSWIRE) -- Bio, Inc. (Nasdaq: IBIO), an AI-driven innovator of precision antibody therapies, today announced a licensing agreement with AstralBio Inc. for a...
-
KUALA LUMPUR, Malaysia, April 16, 2025 (GLOBE NEWSWIRE) -- Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a leading provider of customizable software solutions, announced today...
-
Disguise Secures New Rights to the Core IP for Sonic the Hedgehog™ in Multi-Year Deal with SEGA of America
-
BASKING RIDGE, N.J., April 15, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies...
-
MSD obtains a Non-Exclusive License for Cyprumed’s delivery technology to develop oral peptide therapeuticsCyprumed will be eligible to receive up to $493 million in upfront, development, regulatory...
-
WILMINGTON, Mass., April 14, 2025 (GLOBE NEWSWIRE) -- Liberty Defense Holdings Ltd. (“Liberty” or the “Company”) (TSXV: SCAN, OTCQB: LDDFF, FRANKFURT: FSE:E30), a leading technology provider of...
-
NEW YORK and MONTREAL, April 10, 2025 (GLOBE NEWSWIRE) -- G-III Apparel Group, Ltd. (Nasdaq: GIII) and ALDO Product Services (APS), a division of the ALDO Group, today announced a new strategic...